
Indiana attorney general sues drug companies over EpiPen prices
The 107-page lawsuit claims Mylan and Pfizer conspired to increase EpiPen’s price by more than 600% and prevented similar products from coming to market. Pfizer denied the allegations. Mylan did not immediately respond to a request for comment.